Core needle biopsy is a safe and accurate initial diagnostic procedure for suspected lymphoma |
| |
| Authors: | Brian M. Nguyen Chelsea Halprin Yuliya Olimpiadi Peter Traum James J. Yeh Christine Dauphine |
| |
| Affiliation: | 1. Division of Surgical Oncology, Department of Surgery, Harbor-UCLA Medical Center, 1000 West Carson Box 25, Torrance, CA 90502, USA;2. Department of Pathology, Harbor-UCLA Medical Center, 1000 West Carson Box 25, Torrance, CA 90502, USA;3. Division of Hematology and Medical Oncology, Department of Medicine, Harbor-UCLA Medical Center, 1000 West Carson Box 25, Torrance, CA 90502, USA |
| |
| Abstract: | BackgroundExcisional biopsy is currently recommended for the analysis of lymphadenopathy suspicious for lymphoma. This study aims to evaluate the efficacy and safety of image-guided core needle biopsy (IGCNB) for the diagnosis of lymphoma using a standard protocol for tissue acquisition and analysis.MethodsAll IGCNBs from 2008 to 2014 performed under the study protocol were included in analysis. Demographics, pathology results, additional studies, and follow-up information were recorded.ResultsSeventy-three IGCNBs were performed in 71 consecutive patients. Lymphoma was diagnosed in 37 patients (51%). All 37 patients (100%) were subtyped and treated based on IGCNB results. The remaining 36 IGCNBs in 34 patients did not have subsequent diagnosis of lymphoma in a mean follow-up of 15 months (range, 0 to 54 months). There were no complications.ConclusionsIGCNB performed under a standard protocol is effective and safe and should be considered as an initial diagnostic tool for the evaluation of lymphadenopathy suspicious for lymphoma. |
| |
| Keywords: | Core biopsy Core needle biopsy Lymphoma Diagnosis Ultrasound Ultrasound-guided biopsy |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
